EXEL vs ZION · P/E 17, rev $628.7M vs P/E 11, rev $354.0M
Exelixis Inc (EXEL) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the EXEL and ZION stock pages for the full models.
Not investment advice.